The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: To examine the radiosensitizing effects of iron oxide nanoparticles in the presence of 6 MV (megavoltage) X-ray radiation. MATERIALS AND METHODS: Iron oxide nanoparticles with two different modifications - dextran coating (plain) and amino-group dextran coating - were used. The rate of iron oxide penetration was monitored using Prussian blue staining, magnetic resonance imaging and atomic adsorption spectroscopy. The effect of iron oxide on the viability of cells was determined using trypan blue dye exclusion assay followed by evaluating the cytotoxicity effect of amino-group iron oxide nanoparticles and ionizing radiation. Radiation dose enhancement studies were carried out on DU145 human prostate carcinoma cell line with 1 mg/ml amino-group iron oxide nanoparticles and different doses of 6 MV X-ray radiation. RESULTS: The uptake of amino-group coated nanoparticles by DU145 cells was significantly more than the plain nanoparticles. In addition, cell viability was decreased with the increase of iron oxide concentration. The dose enhancement factor (DEF) is approximately 1.2 at different doses in the range of 2-8 Gy of 6 MV X-ray radiation. CONCLUSIONS: It was demonstrated that iron oxide nanoparticles with the appropriate surface modifications can enter the DU145 cells and it can be used as a cell sensitizer to megavoltage ionizing radiations in radiation therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495 · cited 2×
“…characteristic enables them to evade the immune Keywords: Prostate cancer, radiosensitization, iron oxide nanoparticles, megavoltage radiation therapy, dose enhancement factor system and to be highly taken up by tumor due to the EPR effect (Maeda 2001, Roeske et al. 2007, Hainfeld et al. 2008).”
Background
Cited by
Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications
Beik, J., Abed, Z., Ghoreishi, F. S., Hosseini-Nami, S., Mehrzadi, S., Shakeri-Zadeh, A., & Kamrava, S. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.062 · Cited by 579
Self-citationBiologically Targeted Magnetic Hyperthermia: Potential and Limitations
Chang, D., Lim, M., Goos, J. A. C. M., Qiao, R., Ng, Y. Y., Mansfeld, F. M., Jackson, M., Davis, T. P., & Kavallaris, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00831 · Cited by 495
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment
Yu, Z., Gao, L., Chen, K., Zhang, W., Zhang, Q., Li, Q., & Hu, K. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03489-z · Cited by 138
Bilynsky, C., Millot, N., & Papa, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10256 · Cited by 52
“Nitroimidazole is an imaging agent specific to hypoxia; it manages to sensitize tumors to radiation by generating ROS.88 Researchers have made “smart” nanogels loaded with IAZA (iodoazomycin arabinoside), a nitroimidazole derivative, and functionalized with galactose.”
Background
Metadata
- Authors
- Khoei, S., Mahdavi, S. R., Fakhimikabir, H., Shakeri-Zadeh, A., & Hashemian, A.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2014-02-25
- Volume
- 90
- Issue
- 5
- Pages
- 351-356
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2098245145
- Cited by
- 94
- References
- 1
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. https://app.cochat.ai/papers/10.3109/09553002.2014.888104
- The paper
- Khoei, S., Mahdavi, S. R., Fakhimikabir, H., Shakeri-Zadeh, A., & Hashemian, A. (2014). The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies. International Journal of Radiation Biology. https://doi.org/10.3109/09553002.2014.888104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.